Results 171 to 180 of about 1,141 (182)

Rezafungin acetate. 1,3-beta-Glucan synthase inhibitor, Antifungal agent

Drugs of the Future, 2020
null Chopra, S., null Thakare, R., null Dasgupta, A.   +2 more
openaire   +1 more source

New antifungals development: rezafungin in candidiasis treatment

The Lancet Infectious Diseases
Desnos-Ollivier, Marie, Lanternier, Fanny   +1 more
openaire   +3 more sources

Aneuploidy underlies paradoxical growth of rezafungin and enables cross-tolerance to echinocandins in Candida albicans

Journal of Infection, 2022
Yong-Bing Cao, Tianhua Yan, Feng Yang
exaly  

Comparison of In Vitro Killing Activity of Rezafungin, Anidulafungin, Caspofungin, and Micafungin against Four Candida auris Clades in RPMI-1640 in the Absence and Presence of Human Serum

Microorganisms, 2021
Renátó Kovács, Zoltán Tóth, Andrew M Borman   +2 more
exaly  

Relative Frequency of Paradoxical Growth and Trailing Effect with Caspofungin, Micafungin, Anidulafungin, and the Novel Echinocandin Rezafungin against Candida Species

Journal of Fungi (Basel, Switzerland), 2020
Zoltán Tóth, Renátó Kovács, Andrew M Borman   +2 more
exaly  

Lack of Effect of Rezafungin on QT/QTc Interval in Healthy Subjects

Clinical Pharmacology in Drug Development, 2020
exaly  

Safety Study of Rezafungin to Treat Invasive Fungal Infections

Case Medical Research, 2019
openaire   +1 more source

Rezafungin (CD101), a next-generation echinocandin: A systematic literature review and assessment of possible place in therapy

Journal of Global Antimicrobial Resistance, 2018
Kevin Garey
exaly  

Rezafungin Acetate

openaire   +1 more source

Regulatory Considerations in the Approval of Rezafungin (Rezzayo) for the Treatment of Candidemia and Invasive Candidiasis in Adults

Journal of Infectious Diseases
Abhay Joshi, Irum Syed
exaly